STEPHANIE BLACK: Open Payments
NPI 1386169126 · SHAWNEE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,384 in 145 payments from 21 companies in 2025. Trend: 2023 $35 · 2024 $3,449 · 2025 $3,384
Food & beverage: $3,384
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $547 |
| ABBVIE INC. | 20 | $407 |
| Janssen Biotech, Inc. | 14 | $374 |
| Ardelyx, Inc. | 9 | $293 |
| PFIZER INC. | 14 | $255 |
| Regeneron Healthcare Solutions, Inc. | 7 | $245 |
| Lilly USA, LLC | 13 | $200 |
| Madrigal Pharmaceuticals | 9 | $173 |
| SHIELD THERAPEUTICS INC | 2 | $129 |
| GENZYME CORPORATION | 4 | $104 |
Products named: ENTYVIO, TREMFYA, DUPIXENT, IBSRELA, OMVOH, XELJANZ, REZDIFFRA, SKYRIZI.
Industry payments across KS — which companies pay providers there.
